ICCA Offers HOPE when HOPE is Lost!
ICCA treats advanced metastatic and recurrent cancers at first-class treatment centers in Tijuana, Baja California, Mexico, and satellite locations located in Irvine and Los Angeles, California.
ICCA administers CoNexus Cancer Care, a customized treatment plan that incorporates and combines clinically approved conventional and integrative treatments that are often unavailable to U.S./Canadian patients.
ICCA's primary goal is to instigate significant reduction, shrinkage, or even full necrosis (tumor death) of aggressive metastatic and recurrent cancers, without damaging surrounding tissues or organs, even when classified as "untreatable" by most other cancer treatment centers.
ICCA provides integrative cancer care by keeping the patient at the center of the treatment process. Our team works with you one-on-one and offers customized treatment plans, so your entire CoNexus Cancer Care team becomes your partner during the healing process.
Our treating physician team consists of board-certified Medical Oncologists, Oncologic Surgeons, Interventional Radiologists, and Interventional Anthologists. Radiation Oncologists, and Critical Care Physicians.
At Integrative Cancer Centers of America, we formulate medicines and/or protocols unique to that specific patient's cancer; employ an array of cancer-fighting "tools" often unavailable within the U.S. or Canada; use safe and effective "tools" that have undergone rigorous clinical trials/testing in respected medical centers within Germany, U.S., Cuba (outstanding cancer regiments), UK, South Korea, Mexico, and China, among other advanced nations. These consist of:
ICCA Offers HOPE when HOPE is Lost!
If your cancer team insists you undergo chemotherapy, you should be offered a chemo that has been proven to treat your unique cancer 100%, not a guess because it worked for someone else!
Learn More about Live Cell Tumor ProfilingCoNexus Cancer Care is a customized cancer treatment program that offers global protocols and treatments to Integrative Cancer Centers of America patients.
Learn MoreLearn the major benefits of undergoing Tumor-Targeted Neoadjuvancy (first step treatment) over Conventional Tumor Therapy.